Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aczone Gel 7.5% in Skin of Color Acne
NCT03681470Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2019
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of dapsone in acne vulgaris, sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Global Acne Assessment Score at 12 weeks. Started Apr 2019; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03681470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681470.